Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Extracellular Vesicles as Floating Cancer Biomarkers

Cutaneous Manifestations of Internal Malignancy

Acidosis and Tumor Progression

Cancer Management

Caring for a Loved One with Cancer

TARDIS: The Improved Method of Detecting Breast Cancer

Transforming Cancer Care through Genomic Testing

Why are Cancer Cell Lines Useful?

Overview of Cell Viability and Cytotoxicity

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

What is Cancer of Unknown Primary?

See more featured articles »

What Role do Biobanks Play in Cancer Research?

Assay for Monitoring and Treating Malignant Brain Tumors

Cancer Research

Cancer Epidemiology

Cancer Pain Management

CDK9 and Cancer

Cancer Prevention: Lowering your Risk

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Cancer Symptoms

Cancer Diagnosis

The Biochemistry of Breast Cancer Screening

Microfluidic cancer treatment screen combined with flow cytometry

What is Tumorigenesis?

Myc Mutations and Cancer

What is Immunochemotherapy?

Targeted Cancer Therapies

The Cancer Cell Surface Proteome as a Therapeutic Target

Effects of Social and Economic Deprivation on Cancer Mortality

Insights into Oncofertility

Secondary Brain Cancer

British Pioneers in Cancer Biology

What Causes Cancer?

Living with Cancer Pain

What is Cancer?

Insight into Cancer Vaccines

Cancer Glossary

Hot vs Cold: the differences between tumor types

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Cancer Pain

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer History

Cancer Screening Considerations: Balancing the Benefits and Risks

The Effects of Cancer on Family Life

Pediatric Cancer

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer Pathophysiology

What is the Tumor Microenvironment?

What is Merkel Cell Carcinoma?

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Metastatic Migration in Cancer may be Influenced by Metabolism

Is Cancer a Metabolic Disorder?

Secondary Lung Cancer

Using Biomarkers to Detect Cancer

Hypoxia Markers and Their Importance

Cancer Prognosis

Cancer Classification

Investigating the Molecular Mechanisms of Cancer

Latest Cancer News and Research

New DNA tetrahedron nanostructures improve targeted cancer therapy delivery

Conventional cancer treatments, such as chemotherapy, often lack specificity and can damage both cancerous and healthy cells, leading to severe side effects.

10 Jun 2026

Automated self-driving labs accelerate the search for new medicines

The Acceleration Consortium (AC) at the University of Toronto and the Structural Genomics Consortium (SGC) announced today a formalized partnership to help tackle a persistent challenge in biomedicine and early drug discovery: the development of bioactive molecules with drug-like properties, advancing our understanding of human health and disease and jump-starting new drug discovery programs.

10 Jun 2026

Tranexamic acid reduces surgical transfusions without raising clot risks

A landmark clinical trial published in the prestigious New England Journal of Medicine found that tranexamic acid reduced transfusions across major surgeries without increasing the risk of dangerous blood clots.

10 Jun 2026

New hybrid lens design drastically cuts 3D microscopy costs and complexity

A team led by Raju Tomer, professor of biological sciences at Columbia University, has created a new design for microscopes and microscope lenses that could push 3D tissue imaging beyond state-of-the-art systems while drastically cutting costs and complexity.

10 Jun 2026

Brain injury survivors face higher risk of brain cancer death

Daniel Daneshvar, MD, PhD, director of the HealthSpan Lab and Chief of the Department of Physical Medicine and Rehabilitation at Mass General Brigham, and Charlotte Luster, of the HealthSpan Lab, are the senior and lead authors of a paper published in Neuroepidemiology, "Brain Cancer Mortality following Traumatic Brain Injury (TBI): A TBI Model Systems Study."

10 Jun 2026

GSV hospitals achieve substantially higher delirium screening in older surgical patients

There is a stark gap in how often hospitals screen older adults for postoperative delirium, with verified geriatric surgery programs screening nearly every patient while non-accredited programs screen just half, according to new findings published in the Journal of the American College of Surgeons.

10 Jun 2026

Philanthropic investment expands collaborative network for autoimmune research

NYU Langone Health today announced a new philanthropic investment from longtime supporters Judy and Stewart Colton as part of a $15 million gift shared across three Colton Consortium institutions: NYU Langone, Yale University, and Tel Aviv University.

10 Jun 2026

Real-time 3D ultrasound in augmented reality helps novices perform like experts

Interpreting medical ultrasound images is a difficult task, requiring a technician to look at 2D images and mentally arrange them into a 3D representation of what the tissue looks like.

10 Jun 2026

New AI system classifies brain tumors with unprecedented accuracy

Experts in Heidelberg have developed an AI system that can classify brain tumors with unprecedented accuracy using standard microscopic tissue sections.

10 Jun 2026

Laverock Therapeutics reports key oncology research milestones

Laverock Therapeutics ('Laverock'), a biotechnology company developing disease-responsive advanced therapies through its unique, programmable gene control technology, today announced key in-vivo functional milestones across its T-cell and macrophage oncology programs for solid tumor indications.

From Laverock Therapeutics 10 Jun 2026

New meningioma atlas uncovers clues to tumor aggressiveness

One of the most detailed maps to date of meningioma - the most common brain tumor in adults - reveals how the tumor's surrounding environment helps drive disease behavior and patient outcomes, according to new research from Mayo Clinic.

9 Jun 2026

Statins may help prevent frailty in older adults

Researchers at Mass General Brigham have demonstrated that older U.S. veterans who initiated statin therapy were significantly less likely to develop frailty over time, suggesting that the cholesterol-lowering medications may have healthy aging benefits beyond cardiovascular disease prevention. Results are published in the European Heart Journal.

9 Jun 2026

Apitegromab helps tirzepatide users lose fat while preserving lean mass

A phase 2 trial found that apitegromab plus tirzepatide reduced lean body mass loss by 1.9 kg compared with tirzepatide plus placebo after 24 weeks, while overall weight loss remained similar.

9 Jun 2026

Obesity drug mazdutide reduces weight and waist size in major trial

Once-weekly 9 mg mazdutide produced clinically meaningful weight loss in Chinese adults with obesity, reducing body weight by 16.65% after 60 weeks versus 1.50% with placebo. The phase 3 GLORY-2 trial also found improvements in waist circumference, systolic blood pressure, and lipid markers, but gastrointestinal adverse events were common.

9 Jun 2026

Machine learning model filters out the biological noise in liquid biopsy samples

A machine learning model developed by researchers at the Johns Hopkins Kimmel Cancer Center filters out the biological noise in liquid biopsy samples, helping clinicians better match therapies to their patients' tumors.

9 Jun 2026

Study identifies key protein driving colon cancer drug resistance

One of the most widely used chemotherapeutic agents for colorectal cancer is 5-fluorouracil (5-FU), a cornerstone treatment that has improved outcomes for countless patients.

9 Jun 2026

High obesity levels linked to fewer surgical procedures in Americans

Researchers from LSU's Pennington Biomedical Research Center and collaborating institutions have found that Americans with the highest levels of obesity are undergoing fewer surgical procedures overall.

9 Jun 2026

Radiology AI systems flag breast cancer signs six years before diagnosis

Three commercially available radiology AI systems have shown the potential to flag early signs of breast cancer up to 6 years before a diagnosis, according to a study published in Radiology, the flagship journal of the Radiological Society of North America (RSNA).

9 Jun 2026

New study frames altered protein modifications as cancer drivers

Cancer has often been explained through mutations in deoxyribonucleic acid (DNA) or changes in ribonucleic acid (RNA), but these layers do not fully explain why tumors with similar genetic profiles can behave differently.

9 Jun 2026

Advanced MRI scans predict chronic kidney disease in patients undergoing nephrectomy

An investigator at the Icahn School of Medicine at Mount Sinai has received international recognition for innovative imaging research that may help physicians identify patients at increased risk of chronic kidney disease (CKD) before they undergo surgery for kidney tumors.

9 Jun 2026